Electromed, Inc. (ELMD)
Data as of , from SEC Form 4 filings.
See up to 3 months of ELMD. The 7-day demo opens the 1M and 3M ranges and puts ELMD on your watchlist.
Start 7-day demoLatest ELMD insider trades
James L. Cunniff - OfficerOpen-market sale$254K- James L. Cunniff - OfficerOpen-market sale$61K
About Electromed, Inc. (ELMD)
Electromed Inc is a United States-based company that develops, manufactures and markets airway clearance products that apply High Frequency Chest Wall Oscillation (HFCWO) therapy in pulmonary care for patients of all ages. The company markets its products in the U.S. to the homecare and hospital markets. Its product includes the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The company operates in a single segment: developing, manufacturing, and marketing medical equipment. The company generates revenue from Homecare, Hospital, Homecare Distributor, and Other.
- NEW PRAGUE, MN
- 197
- 2010
- XASE
ELMD Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 2 | 14,500 | |
| Tax withholding / forfeiture | 2 | 3,773 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
ELMD insider transactions (Form 4)
6627 Form 4 filings on record, the earliest from Oct 2, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Bradley M. Nagel - Officer | Grant or award | Common Stock | 4,900 footnote F1 | $0.00 | - | |
| Bradley M. Nagel - Officer | Tax withholding / forfeiture | Common Stock | 1,102 footnote F2 | $27.10 | $30K | |
| Bradley M. Nagel - Officer | Grant or award | Employee Stock Option (right to buy) | 9,600 | $0.00 | - | |
| ||||||
| James L. Cunniff - Officer | Tax withholding / forfeiture | Common Stock | 2,671 footnote F1 | $27.10 | $72K | |
| ||||||
| Bradley M. Nagel - Officer | Tax withholding / forfeiture | Common Stock | 674 footnote F1 | $42.30 | $29K | |
| ||||||
| James L. Cunniff - Officer | Option exercise | Common Stock | 9,700 | $17.25 | $167K | |
| James L. Cunniff - Officer | Open-market sale | Common Stock | 7,003 | $36.25 footnote F1 | $254K | |
| James L. Cunniff - Officer | Open-market sale | Common Stock | 1,671 | $36.80 footnote F2 | $61K | |
| James L. Cunniff - Officer | Open-market sale | Common Stock | 1,026 | $37.77 footnote F3 | $39K | |
| James L. Cunniff - Officer | Option exercise | Employee Stock Option (right to buy) | 9,700 | $0.00 | - | |
| ||||||
| Bradley M. Nagel - Officer | Option exercise | Common Stock | 4,334 | $10.25 | $44K | |
| Bradley M. Nagel - Officer | Option exercise | Common Stock | 5,267 | $10.71 | $56K | |
| Bradley M. Nagel - Officer | Open-market sale | Common Stock | 11,620 | $36.34 footnote F1 | $422K | |
| Bradley M. Nagel - Officer | Open-market sale | Common Stock | 181 | $37.11 footnote F2 | $7K | |
| Bradley M. Nagel - Officer | Option exercise | Employee Stock Option (right to buy) | 4,334 | $0.00 | - | |
| Bradley M. Nagel - Officer | Option exercise | Employee Stock Option (right to buy) | 5,267 | $0.00 | - | |
| ||||||
 Kathleen Skarvan - Director | Option exercise | Common Stock | 40,000 | $3.82 | $153K | |
| Kathleen Skarvan - Director | Open-market sale | Common Stock | 3,562 | $37.33 | $133K | |
| Kathleen Skarvan - Director | Open-market sale | Common Stock | 8,150 | $34.36 footnote F2 | $280K | |
| Kathleen Skarvan - Director | Open-market sale | Common Stock | 19,032 | $35.24 footnote F3 | $671K | |
| Kathleen Skarvan - Director | Open-market sale | Common Stock | 9,256 | $36.26 footnote F4 | $336K | |
| Kathleen Skarvan - Director | Option exercise | Employee Stock Option (right to buy) | 40,000 | $0.00 | - | |
| ||||||
| Kathleen A. Tune - Director | Grant or award | Common Stock | 3,000 footnote F1 | $0.00 | - | |
| ||||||
| Stan K. Erickson - Director | Grant or award | Common Stock | 3,000 footnote F1 | $0.00 | - | |
| ||||||
| Joseph L. Galatowitsch - Director | Grant or award | Common Stock | 3,000 footnote F1 | $0.00 | - | |
| ||||||
| Andrea M. Walsh - Director | Grant or award | Common Stock | 3,000 footnote F1 | $0.00 | - | |
| ||||||
 Andrew Summers - Director | Grant or award | Common Stock | 3,000 footnote F1 | $0.00 | - | |
| ||||||
| Gregory Fluet - Director | Grant or award | Common Stock | 3,000 footnote F1 | $0.00 | - | |
| ||||||
| Kathleen Skarvan - Director | Grant or award | Common Stock | 3,000 footnote F1 | $0.00 | - | |
| ||||||
| Andrew Summers - Director | Open-market sale | Common Stock | 39,378 | $23.68 | $932K | |
| Andrew Summers - Director | Open-market sale | Common Stock | 16,203 | $25.16 | $408K | |
| Andrew Summers - Director | Open-market sale | Common Stock | 6,576 | $25.94 | $171K | |
| Andrew Summers - Director | Open-market sale | Common Stock | 404 | $26.62 | $11K | |
| Andrew Summers - Director | Open-market sale | Common Stock | 3,153 | $24.42 | $77K | |
| James L. Cunniff - Officer | Tax withholding / forfeiture | Common Stock | 1,291 | $23.95 | $31K | |
| James L. Cunniff - Officer | Grant or award | Common Stock | 17,000 | $0.00 | - | |
| James L. Cunniff - Officer | Grant or award | Employee Stock Option (right to buy) | 31,100 | $0.00 | - | |
| Bradley M. Nagel - Officer | Tax withholding / forfeiture | Common Stock | 562 | $23.95 | $13K | |
| Bradley M. Nagel - Officer | Grant or award | Common Stock | 5,300 | $0.00 | - | |
| Bradley M. Nagel - Officer | Grant or award | Employee Stock Option (right to buy) | 9,800 | $0.00 | - | |
| Andrew Summers - Director | Open-market sale | Common Stock | 17,159 | $28.09 | $482K | |
| Andrew Summers - Director | Open-market sale | Common Stock | 1,157 | $28.89 | $33K | |
| Andrew Summers - Director | Open-market sale | Common Stock | 160 | $29.41 | $5K | |
| Andrew Summers - Director | Open-market sale | Common Stock | 17,597 | $28.09 | $494K | |
| Andrew Summers - Director | Open-market sale | Common Stock | 1,169 | $28.81 | $34K | |
| Andrew Summers - Director | Open-market sale | Common Stock | 162 | $29.40 | $5K | |
| Andrew Summers - Director | Open-market sale | Common Stock | 8,370 | $29.97 | $251K | |
| Andrew Summers - Director | Open-market sale | Common Stock | 362 | $30.80 | $11K | |
| Andrew Summers - Director | Open-market sale | Common Stock | 8,731 | $30.18 | $264K | |
| Andrew Summers - Director | Open-market sale | Common Stock | 17,718 | $30.21 | $535K | |
| Andrew Summers - Director | Open-market sale | Common Stock | 17,718 | $30.15 | $534K | |
| Andrew Summers - Director | Open-market sale | Common Stock | 6,366 | $30.10 | $192K | |
| Andrew Summers - Director | Open-market sale | Common Stock | 6,365 | $29.86 | $190K | |
| Andrea M. Walsh - Director | Grant or award | Common Stock | 3,000 | $0.00 | - | |
| Kathleen A. Tune - Director | Grant or award | Common Stock | 3,000 | $0.00 | - | |
| Joseph L. Galatowitsch - Director | Grant or award | Common Stock | 3,000 | $0.00 | - | |
| Stan K. Erickson - Director | Grant or award | Common Stock | 3,000 | $0.00 | - | |
| Andrew Summers - Director | Grant or award | Common Stock | 3,000 | $0.00 | - | |
| Gregory Fluet - Director | Grant or award | Common Stock | 3,000 | $0.00 | - | |
| Kathleen Skarvan - Director | Grant or award | Common Stock | 3,000 | $0.00 | - | |
| Kathleen Skarvan - Director | Open-market sale | Common Stock | 42,453 | $28.16 | $1.20M | |
| Kathleen Skarvan - Director | Open-market sale | Common Stock | 50,602 | $27.92 | $1.41M | |
| Kathleen Skarvan - Director | Open-market sale | Common Stock | 56,945 | $27.97 | $1.59M | |
| James L. Cunniff - Officer | Option exercise | Common Stock | 87,500 | $0.00 | - | |
| James L. Cunniff - Officer | Tax withholding / forfeiture | Common Stock | 34,426 | $21.47 | $739K | |
| James L. Cunniff - Officer | Option exercise | Performance Stock Units | 87,500 | $0.00 | - | |
Item 2.02, 5.02, 7.01, 9.01
Item 2.02, 7.01, 9.01
Recent ELMD Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - |
ELMD insider trading FAQ
What is the latest insider trade for ELMD?
Electromed, Inc. (ELMD) had 2 insider filings in the last 90 days, with the most recent on 2026-09-03. The full record for ELMD runs to 27 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ELMD stock?
No insider purchases of ELMD were filed in the last 90 days.
How many insiders are selling ELMD stock?
No insider sales of ELMD were filed in the last 90 days. 30 sales are on record for this company.
Where can I see ELMD SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ELMD Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Bradley M. Nagel view on EDGAR
- - James L. Cunniff view on EDGAR
- - Bradley M. Nagel view on EDGAR
- - James L. Cunniff view on EDGAR
- - Bradley M. Nagel view on EDGAR
- - Kathleen Skarvan view on EDGAR
- - Kathleen A. Tune view on EDGAR
- - Stan K. Erickson view on EDGAR
- - Joseph L. Galatowitsch view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where ELMD's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ELMD with a 7-day demo
- ELMD on your watchlist
- Every ELMD Form 4 filing on record
- Up to 3 months of ELMD price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
